Cargando…

Pharmacotherapy for Insomnia Disorder in Older Adults

Detalles Bibliográficos
Autores principales:	Grandner, Michael A., Perlis, Michael L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561251/ https://www.ncbi.nlm.nih.gov/pubmed/31880788 http://dx.doi.org/10.1001/jamanetworkopen.2019.18214

Ejemplares similares

Insomnia symptoms predict longer COVID-19 symptom duration
por: Vargas, Ivan, et al.
Publicado: (2023)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Why Treat Insomnia?
por: Perlis, Michael L., et al.
Publicado: (2021)

The natural history of insomnia: predisposing, precipitating, coping, and perpetuating factors over the early developmental course of insomnia
por: Ellis, Jason G, et al.
Publicado: (2021)

Associations between Insomnia Symptoms and Anxiety Symptoms in Adults in a Community Sample of Southeastern Pennsylvania, USA
por: Ghani, Sadia B., et al.
Publicado: (2022)

P129 A substantial percentage of patients with Chronic Insomnia do not appreciably increase Total Sleep Time after Cognitive Behavioural Therapy for Insomnia
por: Scott, H, et al.
Publicado: (2021)

Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
por: Roland, Joshua P., et al.
Publicado: (2021)

The burden of untreated insomnia disorder in a sample of 1 million adults: a cohort study
por: Grandner, Michael, et al.
Publicado: (2023)

Refractory Insomnia in an Adolescent with Total Blindness
por: Tubbs, Andrew S., et al.
Publicado: (2019)

Sleep-disordered Breathing and Insomnia as Cardiometabolic Risk Factors among U.S. Hispanics/Latinx(s)
por: Ghani, Sadia B., et al.
Publicado: (2021)

Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians
por: Asnis, Gregory M., et al.
Publicado: (2015)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
por: Matera, Maria Gabriella, et al.
Publicado: (2023)

Topical Pharmacotherapy for Actinic Keratoses in Older Adults
por: Calzavara-Pinton, Piergiacomo, et al.
Publicado: (2022)

A Drosophila Model of Sleep Restriction Therapy for Insomnia
por: Belfer, Samuel J., et al.
Publicado: (2019)

Suicidal ideation during the COVID-19 pandemic: The role of insomnia
por: Killgore, William D.S., et al.
Publicado: (2020)

Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review
por: Mitchell, Matthew D, et al.
Publicado: (2012)

Substance use disorders among older adults: A review of randomized controlled pharmacotherapy trials
por: Tampi, Rajesh R, et al.
Publicado: (2019)

The Durability of Cognitive Behavioral Therapy for Insomnia in Patients with Chronic Pain
por: Jungquist, Carla R., et al.
Publicado: (2012)

The impact of adding Qi-gong training to pharmacotherapy in post COVID insomnia .A prospective study
por: Mekky, J., et al.
Publicado: (2022)

Pharmacotherapy for acid/peptic disorders.
por: Schubert, M. L.
Publicado: (1996)

Evidence gap on antihyperglycemic pharmacotherapy in frail older adults: A systematic review
por: Bollig, Claudia, et al.
Publicado: (2020)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

Bright green light treatment of depression for older adults [ISRCTN69400161]
por: Loving, Richard T, et al.
Publicado: (2005)

The Mind After Midnight: Nocturnal Wakefulness, Behavioral Dysregulation, and Psychopathology
por: Tubbs, Andrew S., et al.
Publicado: (2022)

Update on Pharmacotherapy in Psychodermatological Disorders
por: Shenoi, Shrutakirthi D., et al.
Publicado: (2020)

Pharmacotherapy in patients with vasomotor disorders
por: Boerhout, C.K.M., et al.
Publicado: (2023)

Acute and Chronic Insomnia: What Has Time and/or Hyperarousal Got to Do with It?
por: Vargas, Ivan, et al.
Publicado: (2020)

Bright light treatment of depression for older adults [ISRCTN55452501]
por: Loving, Richard T, et al.
Publicado: (2005)

Orexin Receptor Competitive Antagonists: A Novel target of the Sedative and hypnotics drugs for the pharmacotherapy of Insomnia
por: Banerjee, Indrajit
Publicado: (2018)

Update on the pharmacotherapy of cerebellar and central vestibular disorders
por: Kalla, Roger, et al.
Publicado: (2016)

Dopaminergic Vulnerability and Motor Impairments in Older Adults: Need for Targeted Pharmacotherapy
por: Bohnen, Nicolaas
Publicado: (2020)

Challenges in the Pharmacotherapy of Urogenital Disorders
por: Michel, Martin C.
Publicado: (2010)

Maintenance Pharmacotherapies for Neuropsychiatric Disorders
por: Richards, Stephanie
Publicado: (2013)

Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials
por: Hellings, Jessica
Publicado: (2023)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
por: Campbell, Noll L, et al.
Publicado: (2015)

Optimising pharmacotherapy in older cancer patients with polypharmacy
por: Vrijkorte, Elze, et al.
Publicado: (2019)

Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population
por: Axmon, Anna, et al.
Publicado: (2019)

Hypomagnesemia Is Associated with Excessive Daytime Sleepiness, but Not Insomnia, in Older Adults
por: Tunc, Muhammed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j20fq3vcaanbtg5pnqcfv5e2ut